Analyst Report: LRCX
1. EXECUTIVE SUMMARY
Lam Research rose 8.23% to $200.44 on Friday 6 November 2026, recovering part of a 16.36% fall the session before. PR Newswire reports that the board authorised a $25 billion share repurchase and a $0.33 quarterly dividend at 16:05 ET on 5 November, after the close, so the buyback explains the rebound and not the preceding drop. The brief attributes the 5 November decline to equipment investors reassessing AI spending, but that rests on a Yahoo Finance headline whose body text was unreadable, so the cause is unconfirmed. Coverage from Barron's and TIKR also credits a wider chip-stock rebound for Friday's gain. The shares closed 16.17% below their 30 October level and 37.13% below the close of 9 October, so the bounce has recovered a small part of a large decline.
2. THE CATALYST
Two separate events fall on two separate sessions.
| Session | Close | Change | Volume | Driver per the brief |
|---|---|---|---|---|
| 2026-10-30 | $239.11 | -6.01% | 18,724,300 | No cause found |
| 2026-11-04 | $221.43 | -4.03% | 14,578,400 | No cause found |
| 2026-11-05 | $185.20 | -16.36% | 31,453,300 | Yahoo Finance headline: equipment investors reassessing AI spending (unconfirmed) |
| 2026-11-06 | $200.44 | +8.23% | 17,947,900 | $25bn buyback and chip-stock rebound |
On 5 November, a Yahoo Finance headline attributed the fall to equipment investors reassessing AI spending. The brief could not read the article body, and a page description asks whether record recent profitability raises the stakes for the next chip-investment cycle. A further headline links broader AI-stock selling to hedge funds protecting 2026 gains, and that one was also not read. The cause of the drop therefore rests on headlines alone.
After the close that day, Lam announced the $25 billion authorisation (PR Newswire). It sits on top of remaining balances from the prior programme, can run through open-market and private transactions including derivatives and structured repurchase agreements, has no end date, can be suspended, and does not oblige the company to buy any stock (PR Newswire; Investing.com). The dividend is payable on 6 January 2027 to holders of record on 2 December 2026. CFO Doug Bettinger said the authorisation reinforces the capital allocation plan and pointed to positioning at key technology inflections and cash generation (PR Newswire). Lam filed an 8-K covering the release the same day (Stocktitan).
On 6 November, Yahoo Finance reported that Applied Materials rose in a chip-equipment rally and credited Lam's buyback with lifting the group. Another Yahoo Finance headline describes U.S. chip stocks bouncing back sharply after Thursday's AI rout.
3. COMPANY PROFILE
Lam Research designs, manufactures, markets, refurbishes and services semiconductor processing equipment used to fabricate integrated circuits. It sells in the United States, China, Korea, Taiwan, Japan, Southeast Asia and Europe. Its products include ALTUS deposition systems for tungsten or molybdenum metallisation, SABRE electrochemical deposition products for copper interconnect, and Striker single-wafer atomic layer deposition products for dielectric films. It sits in the Semiconductor Equipment & Materials industry within Technology, alongside Applied Materials, KLA, Teradyne and Qnity.
The market capitalisation is $250.84bn. The forward P/E is 16.4 against a trailing 29.9, and the dividend yield is 0.71%. The next earnings report is due on 27 January 2027, with a consensus EPS estimate of 2.35 and revenue of $8.64bn. The brief contains no recent results or guidance beyond that, and TradingView's AI-generated summary (to be verified before use) notes that the buyback does not change operating results or guidance.
4. DEEP DIVE ANALYSIS
Do fundamentals justify the move? The buyback gives a financial reason for a rebound, and the brief records no change to operating results or guidance. The authorisation is also non-binding, with no end date and a right to suspend. MarketBeat, relaying RTT News, says it could retire up to 9% of shares. That is a single secondary source and was not checked against the filing. As an inference, the $25 billion figure is about 10% of the $250.84bn market capitalisation, which is consistent with that claim but does not verify it.
Comparable episodes. Lam announced a $5 billion repurchase on 23 January 2019 (SEC 8-K), a smaller programme of the same kind that arrived without a sell-off. The brief found no earlier Lam decline of this scale.
Peers. The other equipment names rose over the same period: AMAT +4.22%, KLAC +6.69%, TER +2.58% and Q +6.32%. Lam's 8.23% gain was the largest in the group, and the S&P 500 rose 0.31%. Yahoo Finance credits Lam's buyback with lifting the group, and an inference is that the sector rebound and the buyback contributed in proportions the brief cannot separate.
Analyst actions. The brief found no rating or target change dated 5 to 6 November. Stockanalysis lists earlier target cuts, including Citi from $450 to $435, UBS from $425 to $400, BofA from $385 to $345, Mizuho from $365 to $360, Needham from $390 to $290 and Morgan Stanley from $385 to $339. MarketBeat lists target increases from Riley ($350 to $390), Jefferies ($315 to $335), Muse ($425 to $500) and Harlan Sur ($300 to $315). Both lists are undated and appear to predate the window.
Bull case. A large capital return supports the shares after a 37.13% fall over 20 sessions. The forward P/E of 16.4 is low relative to the trailing 29.9, which implies analysts expect earnings to grow. Peers rallied as well, which suggests the AI-spending worry eased on Friday.
Bear case. The cause of the 5 November drop is unidentified, so the worry behind it remains unresolved. A Barron's/Benzinga headline says Jim Cramer had "cold feet" on Lam, but it was read only as a headline and predates the buyback. The shares fell in four of the last five sessions before Friday, and the buyback can be suspended.
5. TECHNICAL SNAPSHOT
At $200.44 the shares sit well below both the 50-day average of $284.26 and the 200-day average of $283.63, and 54.2% below the 52-week high of $438.03 set on 30 June, though 48.6% above the 52-week low of $134.88. Friday's volume of 17,947,900 was 1.74x the 50-session average, lower than the 31,453,300 on 5 November. The nearest support is the 5 November close of $185.20. The nearest resistance is the 4 November close of $221.43, with $227.56 above it. The session opened at $208.65 and closed lower, at $200.44, after a high of $209.20, which indicates selling into the early strength.
6. RISK FACTORS
- The 5 November cause is unconfirmed, so the market has not resolved what drove the 16.36% fall.
- The authorisation obliges Lam to buy nothing and can be suspended.
- Hedge-fund selling in AI stocks, per a Yahoo Finance headline, could resume.
- Weak read-across from peers can pressure the group.
Dated events:
| Date | Event |
|---|---|
| 12 November 2026 | Applied Materials fiscal Q4 results (Yahoo Finance) |
| 2 December 2026 | Dividend record date |
| 6 January 2027 | Dividend payment |
| 27 January 2027 | Lam earnings |
7. ACTIONABLE OUTLOOK
Short term (1-2 weeks). Applied Materials' results on 12 November are the main scheduled test for the equipment group. Resistance at $221.43 and support at $185.20 mark the range from the recent closes. A close below $185.20 would put the 52-week low of $134.88 back in view. This is analysis and not personal financial advice.
Medium term (1-3 months). The price depends on whether the AI-spending concern behind the 5 November drop is identified and addressed, and on how fast Lam executes the repurchase, which will show in later filings. The dividend dates fall in this window, and Lam's January earnings sit just inside the three-month mark.
Long-term thesis. The brief shows no change to operating results or guidance, so the long-term thesis rests on the same fundamentals as before the sell-off. The $25 billion authorisation adds a capital-return element.